The U.S. Securities and Exchange Commission (SEC) informed the White House in March that it has made considerable progress ...

The downgrade reflects Vivid Seats’ weaker than expected performance due to a sharp increase in competition. The increased marketing spend by competitors via third-party search engines has led to a ...

Moody’s Ratings has elevated the issuer and senior unsecured ratings of Central Japan Railway Company (JR Central) from A2 to A1, and altered the outlook from positive to stable. The rating upgrade is ...

The short seller’s analysis also calls into question GRAIL’s claims of the Galleri test’s positive predictive value (PPV), suggesting that the company’s comparisons to standard screening tools are ...

Tudor Gold Corp . (TSXV:TUD) and American Creek Resources Ltd . (TSXV:AMK) (OTCQB:ACKRF) have announced a binding letter of intent (LOI) on June 6, 2025, outlining Tudor’s plan to acquire all issued ...

Corp to Equal-weight from Overweight, saying the fast-food giant’s stock already reflects much of its near-term improvement, ...

The project, backed by the Government of Uzbekistan, reinforces Plug Power’s role as a key electrolyzer provider for ...

Shares of PolyPid Ltd. (NASDAQ: PYPD) soared 10.1% following the announcement of positive Phase 3 trial results for its D-PLEX100 product, aimed at preventing sur ...

Shares of Ondas Holdings Inc. (NASDAQ: ONDS) surged 11.2% following the announcement of a substantial $14.3 million purchase order from a key defense customer for ...

TuHURA Biosciences Inc (NASDAQ: HURA) shares climbed 5% today after the U.S. Food and Drug Administration (FDA) lifted a manufacturing-related partial clinical ho ...

Approximately 5.1% of Elevation Oncology’s common stock is held by officers, directors, and affiliates who have agreed to tender their shares in support of the merger. The transaction is slated for ...

Investing.com -- Shares of Axsome Therapeutics Inc (NASDAQ: AXSM) fell 1.2% following the U.S. Food and Drug Administration’s (FDA) Refusal to File (RTF) letter regarding the company’s New Drug ...